AI Raises the Bar for Pharma Ads
The bar for truth and relatability is rising. Brand teams should focus on what AI enables, not how ads are produced.
Benji
Founder
For years, pharma creative has been limited by cost and time:
- one main concept
- a few variations
- long production cycles
- slow learning
So we told fewer stories than could possibly resonate with every patient's experience.
AI changes that.
Used responsibly, AI lets teams:
- explore more patient contexts
- test different tones and messages
- reflect real heterogeneity
- learn faster what actually resonates
This isn't about gaming performance. It's about relevance at scale.
The risk with AI isn't that it's fake. (Nobody took issue with actor portrayals before…) The risk is that it's used carelessly, producing generic empathy, overconfident claims, and unrealistic AI weirdness.
The upside is enormous if you set the bar correctly.
ohohoh.ai is built for teams who want more stories, quicker market response, and faster learning, without sacrificing scientific rigor or trust.
Because the future of pharma creative isn't louder. It's more personal, agile, honest, and human.
Continue reading
Patients Don't Live in "The Hero Spot"
Recognizing patients means showing real life, not just one polished campaign.
The Opportunity for More Patient-First Creative
Patient-first creative is about the patient and the message, not how the ad gets made.
Curious to learn more?
We can show you all the ways ohohoh.ai can unlock your brand's potential.
Ask for a Demo